Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 7/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 6/20 | 0.42 |
| ▸ | TERF2 | Q15554 | 9/20 | 0.38 |
| ▸ | BIRC3 | Q13489 | 3/20 | 0.35 |
| ▸ | XIAP | P98170 | 2/20 | 0.35 |
| ▸ | BIRC2 | Q13490 | 2/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13685776 | 0.90 | TERF2 (0.41) | HDAC1HDAC4TERF2BIRC3XIAP | |
| SCHEMBL13685613 | 0.85 | TERF2 (0.34) | HDAC1HDAC4TERF2BIRC3XIAP | |
| SCHEMBL13685695 | 0.82 | TERF2 (0.41) | TERF2BIRC3XIAPBIRC2 | |
| SCHEMBL13685680 | 0.80 | TERF2 (0.43) | TERF2BIRC3XIAPBIRC2 | |
| SCHEMBL13685777 | 0.78 | HDAC6 (0.33) | HDAC1TERF2BIRC3XIAPBIRC2 | |
| SCHEMBL13685682 | 0.77 | TERF2 (0.36) | TERF2BIRC3XIAPBIRC2 | |
| SCHEMBL8291503 | 0.76 | F2 (0.41) | HDAC1HDAC4TERF2BIRC3XIAP | |
| SCHEMBL13685735 | 0.75 | TERF2 (0.37) | HDAC1HDAC4TERF2BIRC3XIAP | |
| SCHEMBL13685681 | 0.75 | TERF2 (0.34) | TERF2BIRC3XIAPBIRC2 | |
| SCHEMBL13685689 | 0.73 | TERF2 (0.34) | TERF2BIRC3XIAPBIRC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7592419-B2 | Macrocyclic inhibitors of hepatitis C virus NS3-serine protease | SCHERING CORPORATION (US) | 2009-09-22 | — | — | US | disclosed |
| US-7592419-B2 | Macrocyclic inhibitors of hepatitis C virus NS3-serine protease | SCHERING CORPORATION (US) | 2009-09-22 | — | — | US | disclosed |